Obagi Medical Products, Inc. (OMPI) First Quarter 2012 Sales Rose 16% to a Record $30.8 Million; Highest Sales Quarter in Company History  
5/4/2012 10:30:34 AM

LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, today reported that net sales for the first quarter ended March 31, 2012 rose 16% to a record $30.8 million from $26.5 million a year ago.